| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.92▼ | 5.92▼ | 5.92▼ | 5.99▲ | 7.33▼ |
| MA10 | 6.04▼ | 6.23▼ | 6.29▼ | 6.70▼ | N/A |
| MA20 | 6.47▼ | 6.66▼ | 6.66▼ | 7.96▼ | N/A |
| MA50 | 7.03▼ | 7.99▼ | 8.42▼ | N/A | N/A |
| MA100 | 8.61▼ | 7.88▼ | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | 8.913▼ | 5.230▼ | 5.098▼ | 12.193▼ | N/A |
| WILL %R | -98.291▼ | -98.540▼ | -98.561▼ | -87.179▼ | N/A |
| CCI | -91.718 | -96.205 | -96.735 | -87.215 | N/A |
|
Friday, September 13, 2019 08:04 PM
HOUSTON, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancer, announced its support for ...
|
|
Friday, September 13, 2019 10:41 AM
Salarius Pharmaceuticals (NASDAQ:SLRX) appoints CFO Scott Jordan as Chief Business Officer and consultant Mark Rosenblum as EVP Finance and interim CFO. Mr. Jordan joined the company in 2016.
|
|
Friday, September 13, 2019 05:00 AM
HOUSTON, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancer today announced the appointment ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/09/19 | 6.04 | 6.113 | 5.75 | 6.10 | 11,000 |
| 20/09/19 | 5.953 | 6.04 | 5.80 | 5.99 | 45,900 |
| 19/09/19 | 6.03 | 6.20 | 5.60 | 5.81 | 36,700 |
| 18/09/19 | 5.96 | 6.44 | 5.93 | 6.09 | 30,100 |
| 17/09/19 | 6.89 | 6.93 | 5.85 | 5.95 | 51,000 |
| 16/09/19 | 6.98 | 7.16 | 6.48 | 6.89 | 28,400 |
| 13/09/19 | 7.14 | 7.739 | 7.00 | 7.05 | 27,600 |
| 12/09/19 | 7.90 | 7.937 | 5.95 | 7.18 | 117,100 |
| 11/09/19 | 7.96 | 8.421 | 7.85 | 7.90 | 8,100 |
| 10/09/19 | 8.00 | 8.08 | 7.507 | 8.00 | 15,700 |
|
|
||||
|
|
||||
|
|